These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21915676)

  • 1. Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases.
    Hanaoka R; Kurasawa K; Maezawa R; Kumano K; Arai S; Fukuda T
    Mod Rheumatol; 2012 Jun; 22(3):438-45. PubMed ID: 21915676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases.
    Yamashita M; Ishii T; Iwama N; Takahashi H
    Clin Exp Rheumatol; 2006; 24(6):649-55. PubMed ID: 17207380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus infection associated with immunosuppressive therapy in collagen vascular diseases].
    Yoshihara S; Fukuma N; Masago R
    Ryumachi; 1999 Oct; 39(5):740-8. PubMed ID: 10614168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
    Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
    Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?
    Mencarini J; Spinicci M; Bartalesi F
    Reumatismo; 2016 Dec; 68(3):144-147. PubMed ID: 27981816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.
    Busca A; Passera R; Pini M; Zallio F; Dellacasa C; Audisio E; Giaccone L; Maffini E; Costa C; Cavallo R; Bruno B
    Am J Hematol; 2015 Jun; 90(6):E117-21. PubMed ID: 25752810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.
    Iida T; Ikeya K; Watanabe F; Abe J; Maruyama Y; Ohata A; Teruyuki S; Sugimoto K; Hanai H
    Inflamm Bowel Dis; 2013 May; 19(6):1156-63. PubMed ID: 23619714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cytomegalovirus reactivation and dermatomyositis.
    Kanetaka Y; Kano Y; Hirahara K; Kurata M; Shiohara T
    Eur J Dermatol; 2011; 21(2):248-53. PubMed ID: 21398206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
    Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
    J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
    Yoshihara R; Komai T; Shoda H; Fujio K
    Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS).
    Mizukawa Y; Kimishima M; Aoyama Y; Shiohara T
    Int J Infect Dis; 2020 Nov; 100():239-246. PubMed ID: 32891735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case-control study.
    Gardiner BJ; Haas EM; Bailey RC; Chow JK; Snydman DR
    Rheumatol Int; 2019 Jul; 39(7):1229-1240. PubMed ID: 31076831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Reddy V; Meier-Kriesche HU; Greene S; Schold JD; Wingard JR
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):698-705. PubMed ID: 16125640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.